The Cdx2 homeobox gene suppresses intestinal tumorigenesis through non-cell-autonomous mechanisms

© 2018 Balbinot et al..

Developmental genes contribute to cancer, as reported for the homeobox gene Cdx2 playing a tumor suppressor role in the gut. In this study, we show that human colon cancers exhibiting the highest reduction in CDX2 expression belong to the serrated subtype with the worst evolution. In mice, mosaic knockout of Cdx2 in the adult intestinal epithelium induces the formation of imperfect gastric-type metaplastic lesions. The metaplastic knockout cells do not spontaneously become tumorigenic. However, they induce profound modifications of the microenvironment that facilitate the tumorigenic evolution of adjacent Cdx2-intact tumor-prone cells at the surface of the lesions through NF-κB activation, induction of inducible nitric oxide synthase, and stochastic loss of function of Apc This study presents a novel paradigm in that metaplastic cells, generally considered as precancerous, can induce tumorigenesis from neighboring nonmetaplastic cells without themselves becoming cancerous. It unveils the novel property of non-cell-autonomous tumor suppressor gene for the Cdx2 gene in the gut.

Errataetall:

CommentIn: J Exp Med. 2018 Mar 5;215(3):725-727. - PMID 29440363

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:215

Enthalten in:

The Journal of experimental medicine - 215(2018), 3 vom: 05. März, Seite 911-926

Sprache:

Englisch

Beteiligte Personen:

Balbinot, Camille [VerfasserIn]
Armant, Olivier [VerfasserIn]
Elarouci, Nabila [VerfasserIn]
Marisa, Laetitia [VerfasserIn]
Martin, Elisabeth [VerfasserIn]
De Clara, Etienne [VerfasserIn]
Onea, Alina [VerfasserIn]
Deschamps, Jacqueline [VerfasserIn]
Beck, Felix [VerfasserIn]
Freund, Jean-Noël [VerfasserIn]
Duluc, Isabelle [VerfasserIn]

Links:

Volltext

Themen:

CDX2 Transcription Factor
EC 1.14.13.39
Journal Article
NF-kappa B
Nitric Oxide Synthase Type II
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 01.04.2019

Date Revised 01.04.2019

published: Print-Electronic

CommentIn: J Exp Med. 2018 Mar 5;215(3):725-727. - PMID 29440363

Citation Status MEDLINE

doi:

10.1084/jem.20170934

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM280978650